Orphalan

This early-stage trial is testing whether a new once-daily version of the drug trientine (TETA 4HCl) works similarly to the current twice-daily formulation. The study involves healthy adult volunteers who will receive both versions in a crossover design to compare how the drug is…

This study looked at whether people with Wilson's disease prefer a new once-daily version of the drug trientine over their usual treatment, which is taken multiple times a day. Ten adults on stable standard care tried the new formulation and reported their satisfaction and conven…

This study looked at a new blood test that measures copper levels in people with Wilson's disease, a rare condition where copper builds up in the body. Researchers collected extra blood samples from 50 adults during routine visits over about a year. The goal was to see if this te…